(Q43956053)

28 November 2017

title

Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy (English)

1 reference

28 November 2017

1 reference

Dietmar W Siemann

1

1 reference

28 November 2017

Emma Mercer

series ordinal

2

1 reference

28 November 2017

Sharon Lepler

series ordinal

3

1 reference

28 November 2017

Amyn M Rojiani

series ordinal

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Cancer

28 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 November 2017

volume

99

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

1-6

1 reference

Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice

28 November 2017

cites work

1 reference

Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

21 January 2018

1 reference

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

21 January 2018

1 reference

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

21 January 2018

1 reference

Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

21 January 2018

1 reference

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

21 January 2018

1 reference

Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathione-targeted assay

21 January 2018

1 reference

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours

21 January 2018

1 reference

Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes

21 January 2018

1 reference

The Current Status of Targeting Tumour Vasculature as a Means of Cancer Therapy: An Overview

21 January 2018

1 reference

Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid

21 January 2018

1 reference

Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids

21 January 2018

1 reference

Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

21 January 2018

1 reference

Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

Potentiation of cisplatin activity by the bioreductive agent tirapazamine

21 January 2018

1 reference

Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872

21 January 2018

1 reference

Potentiation of combination chemotherapy by nitroheterocyclics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10316

1 reference

28 November 2017

1 reference